Group One Trading
EDIT icon

Group One Trading’s Editas Medicine EDIT Stock Holding History

Group One Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.1K Sell
23,100
-338,800
-94% -$717K ﹤0.01% 5163
2025
Q4 		$742K Buy
361,900
+32,900
+10% +$95K ﹤0.01% 3164
2025
Q3 		$1.14M Sell
329,000
-10,600
-3% -$29.6K ﹤0.01% 2892
2025
Q2 		$747K Buy
339,600
+165,800
+95% +$271K ﹤0.01% 3031
2025
Q1 		$202K Buy
173,800
+152,200
+705% +$224K ﹤0.01% 4006
2024
Q4 		$27.4K Sell
21,600
-31,200
-59% -$79.5K ﹤0.01% 5498
2024
Q3 		$180K Sell
52,800
-26,900
-34% -$117K ﹤0.01% 3716
2024
Q2 		$372K Sell
79,700
-18,200
-19% -$103K ﹤0.01% 2834
2024
Q1 		$726K Sell
97,900
-165,700
-63% -$1.38M ﹤0.01% 2383
2023
Q4 		$2.67M Buy
263,600
+122,500
+87% +$1.08M 0.01% 1623
2023
Q3 		$1.1M Sell
141,100
-162,500
-54% -$1.39M ﹤0.01% 2168
2023
Q2 		$2.5M Buy
303,600
+165,700
+120% +$1.44M 0.01% 1501
2023
Q1 		$1,000K Sell
137,900
-97,700
-41% -$869K ﹤0.01% 2145
2022
Q4 		$2.09M Sell
235,600
-20,300
-8% -$223K ﹤0.01% 1778
2022
Q3 		$3.13M Sell
255,900
-4,300
-2% -$67K 0.01% 1543
2022
Q2 		$3.08M Buy
260,200
+70,200
+37% +$941K ﹤0.01% 1668
2022
Q1 		$3.61M Buy
190,000
+18,800
+11% +$349K ﹤0.01% 1812
2021
Q4 		$4.54M Sell
171,200
-66,800
-28% -$2.3M ﹤0.01% 1791
2021
Q3 		$9.78M Buy
238,000
+16,300
+7% +$893K 0.01% 1077
2021
Q2 		$12.6M Sell
221,700
-17,500
-7% -$646K 0.02% 919
2021
Q1 		$10M Sell
239,200
-10,400
-4% -$592K 0.01% 941
2020
Q4 		$17.5M Buy
249,600
+120,400
+93% +$4.95M 0.03% 512
2020
Q3 		$3.63M Sell
129,200
-222,400
-63% -$7.24M 0.01% 1135
2020
Q2 		$10.4M Buy
351,600
+34,900
+11% +$912K 0.05% 424
2020
Q1 		$6.28M Sell
316,700
-99,000
-24% -$2.5M 0.05% 430
2019
Q4 		$12.3M Buy
415,700
+396,600
+2,076% +$9.91M 0.08% 277
2019
Q3 		$434K Buy
19,100
+4,200
+28% +$104K ﹤0.01% 2448
2019
Q2 		$369K Buy
14,900
+1,700
+13% +$40.6K ﹤0.01% 2413
2019
Q1 		$323K Sell
13,200
-199,100
-94% -$4.51M ﹤0.01% 2315
2018
Q4 		$4.83M Buy
212,300
+111,500
+111% +$3.03M 0.04% 529
2018
Q3 		$3.21M Sell
100,800
-3,500
-3% -$113K 0.03% 839
2018
Q2 		$3.74M Buy
104,300
+28,300
+37% +$1M 0.03% 704
2018
Q1 		$2.52M Buy
76,000
+62,000
+443% +$2.21M 0.03% 842
2017
Q4 		$430K Buy
14,000
+5,800
+71% +$146K ﹤0.01% 2372
2017
Q3 		$197K Sell
8,200
-24,200
-75% -$461K ﹤0.01% 2768
2017
Q2 		$544K Buy
32,400
+12,000
+59% +$216K 0.01% 1919
2017
Q1 		$455K Buy
20,400
+14,600
+252% +$303K 0.01% 1906
2016
Q4 		$94K Buy
5,800
+2,700
+87% +$41K ﹤0.01% 2878
2016
Q3 		$42K Buy
+3,100
New +$63.5K ﹤0.01% 3436

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading's EDIT Position: Q1 2026 in Review

Group One Trading opened a new position in Editas Medicine (EDIT) in Q1 2026: 22,309 shares worth $55.1K. The stake represents ﹤0.01% of the portfolio and ranks #5193 among its holdings. This is a return to the name: Group One Trading previously reported a position in EDIT as recently as Q2 2025.

Group One Trading first reported a position in EDIT in Q3 2016 and has held it in 26 quarters since. The position peaked at $4.43M in Q2 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Group One Trading held 22,309 shares of Editas Medicine worth $55.1K as of Q1 2026.
  • Editas Medicine was a new Group One Trading position in Q1 2026.
  • Editas Medicine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5193 holding.
  • Group One Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 26 quarters since.
  • Group One Trading's Editas Medicine position peaked at $4.43M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.